Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Finasteride may improve prostate cancer treatment outcomes.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Hsc70 protein may influence hair growth by responding to androgens.

Dutasteride and finasteride affect different cell types differently.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Androgen hormones cause hair follicle scarring in hair loss, and finasteride helps reduce it.

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.